These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 23809114)

  • 21. Adeno-associated viral vectors for the treatment of hemophilia.
    High KA; Anguela XM
    Hum Mol Genet; 2016 Apr; 25(R1):R36-41. PubMed ID: 26614390
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Translational data from adeno-associated virus-mediated gene therapy of hemophilia B in dogs.
    Nichols TC; Whitford MH; Arruda VR; Stedman HH; Kay MA; High KA
    Hum Gene Ther Clin Dev; 2015 Mar; 26(1):5-14. PubMed ID: 25675273
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene therapy for hemophilia.
    Ponder KP
    Curr Opin Hematol; 2006 Sep; 13(5):301-7. PubMed ID: 16888433
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene therapy for hemophilia.
    Nathwani AC
    Hematology Am Soc Hematol Educ Program; 2019 Dec; 2019(1):1-8. PubMed ID: 31808868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Update on clinical gene therapy for hemophilia.
    Perrin GQ; Herzog RW; Markusic DM
    Blood; 2019 Jan; 133(5):407-414. PubMed ID: 30559260
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Immune Response to the fVIII Gene Therapy in Preclinical Models.
    Patel SR; Lundgren TS; Spencer HT; Doering CB
    Front Immunol; 2020; 11():494. PubMed ID: 32351497
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Employing a gain-of-function factor IX variant R338L to advance the efficacy and safety of hemophilia B human gene therapy: preclinical evaluation supporting an ongoing adeno-associated virus clinical trial.
    Monahan PE; Sun J; Gui T; Hu G; Hannah WB; Wichlan DG; Wu Z; Grieger JC; Li C; Suwanmanee T; Stafford DW; Booth CJ; Samulski JJ; Kafri T; McPhee SW; Samulski RJ
    Hum Gene Ther; 2015 Feb; 26(2):69-81. PubMed ID: 25419787
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hemophilia A/B.
    Croteau SE
    Hematol Oncol Clin North Am; 2022 Aug; 36(4):797-812. PubMed ID: 35773055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. AAV-based neonatal gene therapy for hemophilia A: long-term correction and avoidance of immune responses in mice.
    Hu C; Lipshutz GS
    Gene Ther; 2012 Dec; 19(12):1166-76. PubMed ID: 22241178
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene Therapy for Hemophilia.
    Nathwani AC; Davidoff AM; Tuddenham EGD
    Hematol Oncol Clin North Am; 2017 Oct; 31(5):853-868. PubMed ID: 28895852
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Complete correction of hemophilia A with adeno-associated viral vectors containing a full-size expression cassette.
    Lu H; Chen L; Wang J; Huack B; Sarkar R; Zhou S; Xu R; Ding Q; Wang X; Wang H; Xiao W
    Hum Gene Ther; 2008 Jun; 19(6):648-54. PubMed ID: 18500941
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Translational Potential of Immune Tolerance Induction by AAV Liver-Directed Factor VIII Gene Therapy for Hemophilia A.
    Samelson-Jones BJ; Arruda VR
    Front Immunol; 2020; 11():618. PubMed ID: 32425925
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene therapy for hemophilia.
    Nathwani AC
    Hematology Am Soc Hematol Educ Program; 2022 Dec; 2022(1):569-578. PubMed ID: 36485127
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gene therapy for hemophilia "A" and "B": efficacy, safety and immune consequences.
    Chuah M; Vandendriessche T
    Verh K Acad Geneeskd Belg; 2007; 69(5-6):315-34. PubMed ID: 18351211
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proteasome inhibitors enhance gene delivery by AAV virus vectors expressing large genomes in hemophilia mouse and dog models: a strategy for broad clinical application.
    Monahan PE; Lothrop CD; Sun J; Hirsch ML; Kafri T; Kantor B; Sarkar R; Tillson DM; Elia JR; Samulski RJ
    Mol Ther; 2010 Nov; 18(11):1907-16. PubMed ID: 20700109
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene therapy for hemophilia.
    Lynch CM
    Curr Opin Mol Ther; 1999 Aug; 1(4):493-9. PubMed ID: 11713765
    [TBL] [Abstract][Full Text] [Related]  

  • 37. State of the art: gene therapy of haemophilia.
    Spencer HT; Riley BE; Doering CB
    Haemophilia; 2016 Jul; 22 Suppl 5():66-71. PubMed ID: 27405679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Haemophilia gene therapy: From trailblazer to gamechanger.
    Evens H; Chuah MK; VandenDriessche T
    Haemophilia; 2018 May; 24 Suppl 6():50-59. PubMed ID: 29878653
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New approaches to gene and cell therapy for hemophilia.
    Ohmori T; Mizukami H; Ozawa K; Sakata Y; Nishimura S
    J Thromb Haemost; 2015 Jun; 13 Suppl 1():S133-42. PubMed ID: 26149014
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liver-Directed Adeno-Associated Viral Gene Therapy for Hemophilia.
    Markusic DM; Herzog RW
    J Genet Syndr Gene Ther; 2012 Jan; 1():1-9. PubMed ID: 23565343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.